Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Wendy Armstrong

Concepts (357)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
63
2024
2730
6.100
 Why?
Epidemics
6
2024
82
2.170
 Why?
Communicable Diseases
8
2023
152
1.970
 Why?
Anti-Retroviral Agents
5
2019
231
1.760
 Why?
Anti-HIV Agents
13
2024
757
1.630
 Why?
Viral Load
13
2023
449
1.210
 Why?
Infectious Disease Medicine
2
2017
12
1.120
 Why?
Continuity of Patient Care
5
2022
273
1.040
 Why?
Internal Medicine
3
2016
242
0.960
 Why?
Social Stigma
2
2024
117
0.940
 Why?
AIDS-Related Opportunistic Infections
5
2019
123
0.940
 Why?
HIV
13
2023
227
0.940
 Why?
Drug Monitoring
2
2016
215
0.800
 Why?
Immune Reconstitution Inflammatory Syndrome
2
2019
18
0.790
 Why?
Internship and Residency
6
2021
1050
0.780
 Why?
Pre-Exposure Prophylaxis
3
2024
205
0.740
 Why?
Adenine
2
2020
258
0.680
 Why?
Antiretroviral Therapy, Highly Active
6
2019
267
0.670
 Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2020
17
0.670
 Why?
Diagnostic Tests, Routine
2
2021
104
0.640
 Why?
Acquired Immunodeficiency Syndrome
7
2022
228
0.640
 Why?
Humans
91
2024
129627
0.620
 Why?
Consumer Advocacy
1
2018
12
0.600
 Why?
Health Services Accessibility
4
2024
903
0.590
 Why?
Career Choice
3
2018
207
0.590
 Why?
Lost to Follow-Up
2
2017
21
0.580
 Why?
United States
25
2024
13871
0.580
 Why?
Health Policy
3
2023
353
0.550
 Why?
Delivery of Health Care
4
2021
898
0.550
 Why?
Substance-Related Disorders
6
2021
1020
0.530
 Why?
CD4 Lymphocyte Count
6
2020
267
0.520
 Why?
Georgia
10
2024
80
0.500
 Why?
Antimicrobial Stewardship
3
2023
107
0.480
 Why?
Medication Adherence
2
2017
558
0.480
 Why?
Disease Management
1
2019
588
0.480
 Why?
HIV-Associated Lipodystrophy Syndrome
1
2014
12
0.460
 Why?
Biomedical Research
2
2018
640
0.450
 Why?
Urban Population
1
2017
443
0.450
 Why?
Bone Diseases
1
2014
57
0.440
 Why?
Financing, Government
1
2014
43
0.430
 Why?
HIV-1
5
2016
838
0.430
 Why?
Patient Acceptance of Health Care
2
2017
761
0.430
 Why?
Metabolic Diseases
1
2014
104
0.420
 Why?
Rural Population
1
2017
516
0.410
 Why?
Drug Resistance, Viral
2
2005
110
0.410
 Why?
Ventriculostomy
1
2012
21
0.380
 Why?
Chronic Pain
3
2021
253
0.380
 Why?
Ambulatory Care
2
2021
506
0.380
 Why?
Medication Errors
1
2012
96
0.370
 Why?
Mycoses
1
2012
72
0.370
 Why?
Critical Care
1
2016
551
0.360
 Why?
Central Nervous System Diseases
1
2012
69
0.360
 Why?
Prostheses and Implants
1
2012
135
0.350
 Why?
Disease Transmission, Infectious
1
2011
55
0.340
 Why?
Gram-Positive Bacterial Infections
2
2008
64
0.340
 Why?
Analgesics, Opioid
5
2021
913
0.340
 Why?
Cellulitis
2
2011
49
0.330
 Why?
Bacterial Infections
1
2012
235
0.330
 Why?
Microbiology
3
2014
24
0.330
 Why?
Physicians
5
2019
866
0.330
 Why?
Global Health
2
2018
328
0.310
 Why?
Dermatitis
1
2008
19
0.310
 Why?
Male
39
2024
63671
0.310
 Why?
Female
40
2024
68735
0.310
 Why?
Medical Informatics
1
2009
99
0.300
 Why?
Patient-Centered Care
1
2014
508
0.300
 Why?
Adult
32
2024
35600
0.300
 Why?
Education, Medical, Graduate
5
2023
442
0.300
 Why?
Gram-Negative Bacterial Infections
1
2008
45
0.300
 Why?
Middle Aged
31
2024
31136
0.290
 Why?
Information Dissemination
1
2009
205
0.280
 Why?
Africa, Eastern
2
2017
12
0.280
 Why?
AIDS Vaccines
2
2005
47
0.280
 Why?
Periodicals as Topic
1
2009
204
0.270
 Why?
Internet
2
2014
618
0.260
 Why?
Developing Countries
3
2017
284
0.260
 Why?
Pneumonia, Pneumocystis
4
2015
36
0.260
 Why?
Curriculum
5
2023
920
0.260
 Why?
Mycobacterium chelonae
1
2005
8
0.250
 Why?
Databases, Factual
2
2019
1269
0.250
 Why?
Rilpivirine
1
2024
7
0.230
 Why?
Fellowships and Scholarships
4
2023
276
0.220
 Why?
Skin
1
2008
727
0.220
 Why?
Interviews as Topic
2
2017
704
0.210
 Why?
Cost-Benefit Analysis
3
2021
569
0.210
 Why?
Meningoencephalitis
1
2003
25
0.210
 Why?
West Nile virus
1
2003
38
0.210
 Why?
Pyridones
1
2024
158
0.200
 Why?
Practice Guidelines as Topic
3
2019
1501
0.200
 Why?
Pain Management
3
2021
324
0.200
 Why?
Bacteria
1
2008
814
0.190
 Why?
Simulation Training
1
2023
82
0.190
 Why?
Anti-Infective Agents
3
2015
247
0.190
 Why?
Coronary Artery Bypass
1
2003
224
0.190
 Why?
Erythrocyte Transfusion
1
2003
181
0.180
 Why?
Colony-Stimulating Factors
1
2001
35
0.180
 Why?
Mass Screening
2
2020
1190
0.180
 Why?
Obesity
1
2014
2882
0.180
 Why?
Registries
2
2019
1899
0.180
 Why?
Contact Tracing
1
2020
24
0.180
 Why?
Sexual and Gender Minorities
1
2024
196
0.170
 Why?
Prescription Drug Misuse
1
2021
39
0.170
 Why?
Mycobacterium Infections, Nontuberculous
1
2005
353
0.170
 Why?
Cities
4
2022
105
0.170
 Why?
Erythropoietin
1
2001
88
0.170
 Why?
Models, Theoretical
2
2021
546
0.170
 Why?
Life Expectancy
1
2020
60
0.160
 Why?
Health Equity
1
2021
87
0.160
 Why?
Cross-Sectional Studies
5
2021
5075
0.160
 Why?
Policy
1
2021
143
0.160
 Why?
Interleukin-2
1
2001
437
0.160
 Why?
Alanine
1
2020
142
0.160
 Why?
Fever of Unknown Origin
1
1999
10
0.160
 Why?
Heart Diseases
1
2022
352
0.150
 Why?
Mentors
2
2018
177
0.150
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2019
37
0.150
 Why?
Prevalence
5
2024
2564
0.150
 Why?
Comorbidity
2
2020
1547
0.150
 Why?
Tenofovir
1
2020
232
0.150
 Why?
Pandemics
3
2021
1491
0.150
 Why?
Microbial Sensitivity Tests
3
2016
348
0.150
 Why?
Hospitalization
4
2020
2057
0.140
 Why?
Cohort Studies
6
2019
5426
0.140
 Why?
Physician Assistants
1
2019
88
0.140
 Why?
Anti-Bacterial Agents
4
2011
1705
0.140
 Why?
Capital Financing
1
2017
7
0.140
 Why?
Patient Identification Systems
1
2017
16
0.140
 Why?
Sustained Virologic Response
1
2017
37
0.140
 Why?
Africa
1
2017
99
0.140
 Why?
Nurse Practitioners
1
2019
131
0.140
 Why?
Research Personnel
1
2018
156
0.130
 Why?
Viral Tropism
1
2016
29
0.130
 Why?
Financing, Personal
1
2016
26
0.130
 Why?
Opioid-Related Disorders
2
2021
483
0.130
 Why?
Case Management
1
2016
63
0.130
 Why?
Risk Factors
6
2019
9786
0.120
 Why?
Hospitals
2
2021
637
0.120
 Why?
Motivation
2
2017
547
0.120
 Why?
Pneumonia, Viral
1
2020
340
0.120
 Why?
Coronavirus Infections
1
2020
334
0.120
 Why?
Drug Utilization Review
1
2015
57
0.120
 Why?
Time-to-Treatment
1
2017
179
0.120
 Why?
Organizational Policy
1
2015
79
0.120
 Why?
HIV Protease Inhibitors
1
2015
68
0.120
 Why?
Patient Navigation
1
2016
78
0.120
 Why?
Esophageal Diseases
1
2015
27
0.120
 Why?
Online Systems
1
2014
22
0.120
 Why?
Candidiasis
1
2015
57
0.120
 Why?
Pregnancy Complications, Infectious
1
2019
368
0.120
 Why?
Cytosol
1
2015
219
0.110
 Why?
Healthcare Disparities
1
2020
578
0.110
 Why?
Organophosphates
1
2015
120
0.110
 Why?
Alcoholism
1
2021
765
0.110
 Why?
Ambulatory Care Facilities
1
2016
226
0.110
 Why?
Drug Interactions
1
2015
395
0.110
 Why?
Patient Readmission
1
2019
653
0.110
 Why?
DNA, Viral
2
2012
347
0.100
 Why?
Telemedicine
1
2021
792
0.100
 Why?
Aged
8
2022
22061
0.100
 Why?
Health Plan Implementation
1
2014
137
0.100
 Why?
Dihydropteroate Synthase
2
2004
3
0.100
 Why?
Pilot Projects
2
2017
1592
0.100
 Why?
Incidence
2
2021
2641
0.100
 Why?
Retrospective Studies
7
2022
14522
0.100
 Why?
Medication Reconciliation
1
2012
28
0.100
 Why?
Leukocytes, Mononuclear
1
2015
546
0.100
 Why?
Myocardial Infarction
2
2019
1021
0.100
 Why?
Longitudinal Studies
2
2019
2720
0.100
 Why?
Oligopeptides
1
2014
258
0.100
 Why?
HIV Antibodies
1
2012
57
0.100
 Why?
Socioeconomic Factors
2
2020
1213
0.100
 Why?
Primary Health Care
2
2019
1686
0.090
 Why?
Mycobacterium haemophilum
1
2011
1
0.090
 Why?
Electronic Health Records
1
2019
973
0.090
 Why?
Catheter-Related Infections
1
2012
72
0.090
 Why?
Parasitic Diseases
1
2011
8
0.090
 Why?
Research
1
2014
419
0.090
 Why?
Cytomegalovirus
1
2012
154
0.090
 Why?
Pneumocystis
2
2001
11
0.090
 Why?
Health Care Costs
1
2014
367
0.090
 Why?
Mycobacterium Infections
1
2011
62
0.090
 Why?
Simian Immunodeficiency Virus
1
2011
86
0.090
 Why?
Surveys and Questionnaires
5
2023
5415
0.090
 Why?
Simian Acquired Immunodeficiency Syndrome
1
2011
84
0.090
 Why?
Education, Medical, Undergraduate
1
2013
178
0.090
 Why?
Pyridines
1
2014
478
0.090
 Why?
Geography
1
2011
187
0.080
 Why?
Sulfonamides
1
2014
497
0.080
 Why?
Cytomegalovirus Infections
1
2012
189
0.080
 Why?
Deep Brain Stimulation
1
2012
125
0.080
 Why?
Rectum
1
2011
170
0.080
 Why?
Antibodies, Neutralizing
1
2012
267
0.080
 Why?
Desiccation
1
2009
20
0.080
 Why?
Colon
1
2011
254
0.080
 Why?
Emigrants and Immigrants
1
2011
122
0.080
 Why?
Education, Medical, Continuing
1
2009
122
0.080
 Why?
Drug Therapy, Combination
3
2014
1042
0.070
 Why?
Syphilis, Cutaneous
1
2007
3
0.070
 Why?
Immunoglobulin G
1
2012
851
0.070
 Why?
Specimen Handling
1
2009
162
0.070
 Why?
Dendritic Cells
1
2011
481
0.070
 Why?
Adolescent
4
2021
20412
0.070
 Why?
Plasma
1
2009
205
0.070
 Why?
Hepacivirus
1
2009
239
0.070
 Why?
Treatment Outcome
6
2024
10219
0.070
 Why?
Risk Assessment
3
2019
3262
0.070
 Why?
B-Lymphocytes
1
2012
816
0.070
 Why?
Hepatitis C
1
2009
243
0.060
 Why?
HIV-2
1
2005
18
0.060
 Why?
CD4-Positive T-Lymphocytes
1
2011
1058
0.060
 Why?
Diagnosis, Differential
2
2007
1432
0.060
 Why?
Sex Factors
1
2011
1970
0.060
 Why?
Dapsone
2
2004
7
0.060
 Why?
Patient Education as Topic
1
2009
737
0.060
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
2
2004
38
0.060
 Why?
Pneumocystis carinii
1
2004
11
0.060
 Why?
Chronic Disease
2
2012
1720
0.060
 Why?
Virulence
1
2005
255
0.050
 Why?
Mediastinitis
1
2003
3
0.050
 Why?
Vancomycin Resistance
1
2003
12
0.050
 Why?
Young Adult
2
2021
12455
0.050
 Why?
Enterococcus faecium
1
2003
14
0.050
 Why?
Delayed-Action Preparations
1
2024
172
0.050
 Why?
Wound Healing
1
2005
307
0.050
 Why?
Fatal Outcome
1
2003
300
0.050
 Why?
Liver Failure
1
2002
91
0.050
 Why?
Biopsy
1
2005
1088
0.050
 Why?
Cryptococcosis
1
2001
26
0.050
 Why?
Adipose Tissue
1
2005
591
0.050
 Why?
Transplantation, Homologous
1
2002
402
0.050
 Why?
Dental Care
1
2021
26
0.050
 Why?
Intracranial Hypertension
1
2001
37
0.050
 Why?
Time Factors
3
2019
6555
0.050
 Why?
Mutation
2
2004
3717
0.050
 Why?
Coronary Disease
2
2003
385
0.050
 Why?
Naphthoquinones
1
2001
19
0.040
 Why?
Blood
2
2012
105
0.040
 Why?
Cytochrome b Group
1
2001
19
0.040
 Why?
Quality-Adjusted Life Years
1
2021
106
0.040
 Why?
Renal Insufficiency
1
2002
150
0.040
 Why?
Patient Outcome Assessment
1
2021
126
0.040
 Why?
Trust
1
2021
115
0.040
 Why?
Meningitis
1
2001
79
0.040
 Why?
Prospective Studies
1
2012
7135
0.040
 Why?
Neutropenia
1
2001
137
0.040
 Why?
Antifungal Agents
1
2001
130
0.040
 Why?
Personal Satisfaction
1
2021
201
0.040
 Why?
Anemia
1
2001
161
0.040
 Why?
JC Virus
1
2019
23
0.040
 Why?
Antiviral Agents
1
2005
715
0.040
 Why?
Spinal Diseases
1
1999
47
0.040
 Why?
Asymptomatic Infections
1
2019
26
0.040
 Why?
Polyomavirus Infections
1
2019
27
0.040
 Why?
Boston
1
2019
89
0.040
 Why?
Esophageal Stenosis
1
1999
51
0.040
 Why?
Polymerase Chain Reaction
3
2011
1035
0.040
 Why?
Insurance, Health
1
2021
267
0.040
 Why?
Abscess
1
1999
73
0.040
 Why?
Health Status Disparities
1
2021
256
0.040
 Why?
Training Support
1
2018
28
0.040
 Why?
Benchmarking
1
2019
176
0.040
 Why?
Preceptorship
1
2018
63
0.040
 Why?
Substance Abuse Detection
1
2019
79
0.040
 Why?
Multicenter Studies as Topic
1
2019
286
0.040
 Why?
Recombinant Proteins
1
2001
1308
0.040
 Why?
Heart-Assist Devices
1
2003
537
0.030
 Why?
Patient Satisfaction
1
2021
633
0.030
 Why?
Dyslipidemias
1
2019
177
0.030
 Why?
Hospitals, Public
1
2017
26
0.030
 Why?
Drug Administration Schedule
1
2019
767
0.030
 Why?
Medicare
1
2022
708
0.030
 Why?
Prenatal Care
1
2019
277
0.030
 Why?
Odds Ratio
1
2019
1019
0.030
 Why?
Needs Assessment
1
2018
357
0.030
 Why?
Public Health Surveillance
1
2016
68
0.030
 Why?
Postpartum Period
1
2019
333
0.030
 Why?
Delayed Diagnosis
1
2016
79
0.030
 Why?
Multivariate Analysis
1
2019
1499
0.030
 Why?
Stents
1
1999
504
0.030
 Why?
Guideline Adherence
1
2019
527
0.030
 Why?
Motivational Interviewing
1
2016
101
0.030
 Why?
Societies, Medical
1
2018
744
0.030
 Why?
Neopterin
1
2014
12
0.030
 Why?
Darunavir
1
2014
18
0.030
 Why?
Atazanavir Sulfate
1
2014
41
0.030
 Why?
Ritonavir
1
2014
73
0.030
 Why?
Randomized Controlled Trials as Topic
1
2019
1365
0.030
 Why?
Blood Proteins
1
2014
244
0.020
 Why?
Inpatients
1
2016
475
0.020
 Why?
Transplantation
1
2012
31
0.020
 Why?
Smoking
1
2019
1500
0.020
 Why?
Rifabutin
1
2011
6
0.020
 Why?
Clarithromycin
1
2011
28
0.020
 Why?
Ofloxacin
1
2011
24
0.020
 Why?
Viremia
1
2012
131
0.020
 Why?
Quality of Life
1
2023
2688
0.020
 Why?
Receptors, Immunologic
1
2012
217
0.020
 Why?
Macaca mulatta
1
2011
151
0.020
 Why?
Integrins
1
2011
94
0.020
 Why?
RNA, Viral
1
2014
620
0.020
 Why?
Practice Patterns, Physicians'
1
2019
1271
0.020
 Why?
Data Interpretation, Statistical
1
2012
337
0.020
 Why?
Programmed Cell Death 1 Receptor
1
2012
232
0.020
 Why?
Hypertension
1
2019
1243
0.020
 Why?
Immunocompromised Host
1
2011
199
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
756
0.020
 Why?
Health Promotion
1
2015
720
0.020
 Why?
Blotting, Western
1
2011
1206
0.020
 Why?
Neoplasms
1
2002
2455
0.020
 Why?
Feces
1
2011
442
0.020
 Why?
Protein Binding
1
2014
2124
0.020
 Why?
False Negative Reactions
1
2007
53
0.020
 Why?
Flow Cytometry
1
2011
1159
0.020
 Why?
Lymphocyte Activation
1
2011
1109
0.020
 Why?
Cardiovascular Diseases
1
2019
2006
0.020
 Why?
Pregnancy
1
2019
6417
0.020
 Why?
Gene Expression Profiling
1
2011
1687
0.010
 Why?
Genotype
1
2009
1833
0.010
 Why?
T-Lymphocytes
1
2012
1936
0.010
 Why?
Chemoprevention
1
2004
91
0.010
 Why?
China
1
2004
192
0.010
 Why?
Infant
1
2016
8995
0.010
 Why?
Child, Preschool
1
2016
10490
0.010
 Why?
Atovaquone
1
2001
3
0.010
 Why?
Reproducibility of Results
1
2009
3080
0.010
 Why?
Survival
1
2001
38
0.010
 Why?
Ubiquinone
1
2001
28
0.010
 Why?
Gene Amplification
1
2001
104
0.010
 Why?
Cardiomyopathy, Dilated
1
2003
381
0.010
 Why?
Postoperative Complications
2
2003
2477
0.010
 Why?
Biomarkers
1
2011
3968
0.010
 Why?
Sulfones
1
2000
108
0.010
 Why?
Epidural Space
1
1999
10
0.010
 Why?
Animals
2
2011
35391
0.010
 Why?
Radiotherapy, Adjuvant
1
1999
208
0.010
 Why?
Recurrence
1
2001
1011
0.010
 Why?
Radiation Injuries
1
1999
135
0.010
 Why?
Polymorphism, Genetic
1
2001
637
0.010
 Why?
Heart Transplantation
1
2003
721
0.010
 Why?
Esophagus
1
1999
248
0.010
 Why?
Child
1
2016
20884
0.010
 Why?
Molecular Sequence Data
1
2001
2835
0.010
 Why?
Esophageal Neoplasms
1
1999
297
0.010
 Why?
Follow-Up Studies
1
2003
4894
0.010
 Why?
Carcinoma, Squamous Cell
1
1999
627
0.010
 Why?
Case-Control Studies
1
2001
3378
0.010
 Why?
Angina Pectoris
1
1971
67
0.010
 Why?
Tomography, X-Ray Computed
1
1999
2512
0.010
 Why?
Coronary Vessels
1
1971
239
0.000
 Why?
Aorta
1
1971
408
0.000
 Why?
Magnetic Resonance Imaging
1
1999
3394
0.000
 Why?
Angiocardiography
1
1971
1
0.000
 Why?
Extracorporeal Circulation
1
1971
13
0.000
 Why?
Methods
1
1971
64
0.000
 Why?
Saphenous Vein
1
1971
32
0.000
 Why?
Transplantation, Autologous
1
1971
213
0.000
 Why?
Emergencies
1
1971
156
0.000
 Why?
Armstrong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (357) concept(s)
_
Co-Authors Expand Description
See all (3) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)